Info
AE_ALPELISIB
**Adverse effects such as hyperglycemia (~60%), diarrhea (~50%), nausea (44%), anorexia, skin rash (35%), vomiting (27%), stomatitis (24%), fatigue, alopeia (~20%), mucositis, pruritis, headache, and arthralgia. AEAXITINIB **AEs such as diarrhea, hypertension, fatigue, anorexia, nausea, loss of vice, HFS, weight loss, and vomiting, less AEs such as hematuria (3%), tinnitus (3%), lipase increased (3%), rectal hemorrhage (2%), hemoptysis (2%), DVT (1%), and TIA (1%)
Siblings
- AE_ABVD
- AE_ACT
- AE_ALECTINIB
- AE_ALIMTA
- AE_ALPELISIB
- AE_BENDAMUSTINE
- AE_CCRT
- AE_CDK46
- AE_CRIZOINIB
- AE_DABRAFENIB
- AE_ENHERTU
- AE_ERIBULIN
- AE_FOLFOX
- AE_GLIVEC
- AE_HERCEPTIN
- AE_LANREOTIDE
- AE_LAPATINIB
- AE_LAR
- AE_LETROZOLE
- AE_OLAPARIB
- AE_OSIMERTINIB
- AE_PAZOPANIB
- AE_PEMIGATINIB
- AE_PERTUZUMAB
- AE_RAMUCIRUMAB
- AE_RECTAL
- AE_REGORAFENIB
- AE_SORAFENIB
- AE_SUNITINIB
- AE_TAS102
- AE_TAXOTERECDDP
- AE_TOPOTECAN
- AE_UFT
- AE_VEMURAFENIB
- AE_VINORELBINE
- AE_XELOX